Skip to main content
Davendra Sohal, MD, Oncology, Cincinnati, OH, University of Cincinnati Medical Center

DavendraPratap SinghSohalMDMPH

Oncology • Cincinnati, OH

Gastrointestinal Cancer, Hematologic Oncology

Professor of Medicine; Associate Director for Clinical Research at the University of Cincinnati Cancer Center

Join to view full profile

Dr. Sohal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sohal's full profile

Already have an account?

Summary

  • Dr. Davendra Sohal is an oncologist at the University of Cincinnati. His clinical focus is gastrointestinal malignancies, and his research focus is clinical trials, including Phase I trials, precision oncology trials, and multidisciplinary studies.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2005 - 2008
  • University of Alabama at Birmingham
    University of Alabama at BirminghamMPH, Epidemiology and Biostatistics, 2003 - 2005
  • All India Institute of Medical Sciences
    All India Institute of Medical SciencesClass of 2002, MD

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2012 - 2026
  • PA State Medical License
    PA State Medical License 2009 - 2012
  • NY State Medical License
    NY State Medical License 2008 - 2010
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A pilot clinical trial of p53/p16-independent epigenetic therapy for pancreatic ductal adenocarcinoma (PDA). 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
  • SWOG S1505: Initial findings on eligibility and neoadjuvant chemotherapy experience with mFOLFIRINOX versus gemcitabine/nab-paclitaxel for resectable pancreatic adenoc... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Accelerating advanced precision medicine through a harmonized data exchange platform and research consortium (PMEC). 
    2019 ASCO Annual Meeting - 6/1/2019
  • Join now to see all

Press Mentions

  • University of Cincinnati Researcher Receives Catalyst Research Award to Further Cancer Research
    University of Cincinnati Researcher Receives Catalyst Research Award to Further Cancer ResearchDecember 7th, 2021
  • Pre-Surgery Chemotherapy Is Possible for Early Stage Pancreatic Cancer Patients
    Pre-Surgery Chemotherapy Is Possible for Early Stage Pancreatic Cancer PatientsJanuary 21st, 2021
  • IP Paclitaxel Add-on Promising in Pancreatic Cancer
    IP Paclitaxel Add-on Promising in Pancreatic CancerJuly 14th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Davendra Sohal, Dr. Davendra Sohal, MD, Dr. D Sohal, Dr. Davendra Pratap Singh Sohal